Abstract 1106: Co-administration of the iRGD tumor-penetrating peptide improves the tumor immunostimulatory effects of low-dose IL-2
Year: 2019
Type: conference-abstract
Source: Cancer Research
Institution: Sanford Burnham Prebys Medical Discovery Institute
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2954370095
